Market cap
$52,427 Mln
Revenue (TTM)
$250,549 Mln
P/E Ratio
34.1
P/B Ratio
16.1
Div. Yield
0.9 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$1,156 Mln
-
ROE
0 %
-
ROCE
34.8 %
-
Industry P/E
33.27
-
EV/EBITDA
17.6
-
Debt to Equity
-2.9
-
Book Value
$--
-
EPS
$6.6
-
Face value
--
-
Shares outstanding
234,205,855
10 Years Aggregate
CFO
$25,059.00 Mln
EBITDA
$26,821.00 Mln
Net Profit
$2,962.00 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Cardinal Health (CAH)
| 10.7 | 16.5 | 4.8 | 40.9 | 36.6 | 31.3 | 11.5 |
|
BSE Sensex
| -9.3 | 2.1 | 3.0 | -5.3 | 6.9 | 7.8 | 11.1 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Cardinal Health (CAH)
| 73.8 | 17.2 | 31.1 | 49.3 | -0.4 | 10.1 | 18.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Cardinal Health (CAH)
|
227.5 | 52,427.0 | 250,549.0 | 1,559.0 | 0.9 | -- | 34.1 | 16.1 |
| 347.9 | 191,704.4 | 37,238.0 | 7,800.0 | 31.7 | 82.9 | 24.7 | 20.9 | |
| 195.9 | 29,534.8 | 9,857.4 | 1,372.4 | 18.4 | 7.4 | 21.5 | 1.6 | |
| 55.7 | 116,663.5 | 48,482.0 | 7,275.0 | 21.6 | 37.7 | 16 | 5.8 | |
| 126.5 | 155,928.8 | 29,734.0 | 9,216.0 | 39.5 | 40.9 | 17.1 | 6.6 | |
| 782.7 | 94,623.4 | 403,430.0 | 4,762.0 | 1.6 | -246.4 | 20.5 | 5.0 | |
| 115.0 | 298,256.0 | 65,593.0 | 8,935.0 | 24.7 | 18.3 | 34 | 6.4 | |
| 151.0 | 293,693.5 | 56,053.0 | 13,533.8 | 30.3 | 32.7 | 22.1 | 7.6 | |
| 26.0 | 149,154.5 | 63,315.0 | 7,491.0 | 16.7 | 8.1 | 20 | 1.6 | |
| 78.6 | 33,358.0 | 9,509.0 | 2,643.0 | 37.3 | 61.2 | 13 | 10.3 |
Shareholding Pattern
View DetailsAbout Cardinal Health (CAH)
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company... provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio. Read more
-
CEO & Director
Mr. Jason M. Hollar
-
CEO & Director
Mr. Jason M. Hollar
-
Headquarters
Dublin, OH
-
Website
FAQs for Cardinal Health (CAH)
What is the current share price of Cardinal Health Inc (CAH) Today?
The share price of Cardinal Health Inc (CAH) is $227.47 (NYSE) as of 16-Jun-2026 14:49 EDT. Cardinal Health Inc (CAH) has given a return of 36.64% in the last 3 years.
What is the current PB & PE ratio of Cardinal Health Inc (CAH)?
The P/E ratio of Cardinal Health Inc (CAH) is 34.12 times as on 12-Jun-2026, a 3 premium to its peers’ median range of 33.27 times.
The P/B ratio of Cardinal Health Inc (CAH) is 16.07 times as on 12-Jun-2026, a 178 premium to its peers’ median range of 5.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
25.83
|
-14.50
|
|
2024
|
28.27
|
-7.50
|
|
2023
|
72.79
|
-8.12
|
|
2022
|
-15.32
|
-20.27
|
|
2021
|
27.38
|
9.34
|
What is the 52 Week High and Low of Cardinal Health Inc (CAH)?
The 52-week high and low of Cardinal Health Inc (CAH) are Rs 233.60 and Rs 137.75 as of 17-Jun-2026.
What is the market cap of Cardinal Health Inc (CAH)?
Cardinal Health Inc (CAH) has a market capitalisation of $ 52,427 Mln as on 12-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Cardinal Health Inc (CAH)?
Before investing in Cardinal Health Inc (CAH), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.